ISM 9682A
Alternative Names: ISM-9682ALatest Information Update: 04 Jul 2024
At a glance
- Originator InSilico Medicine
- Class Antineoplastics
- Mechanism of Action KIF18A protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer